Syndax Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Syndax Pharmaceuticals, Inc.

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the …

Biotechnology
US, Waltham [HQ]